Experimental study demonstrates optimized growth medium increases zeaxanthin yield in Lutimonas zeaxanthinifaciens, highlighting its potential as a sustainable marine bioproduction source.
Zeaxanthin is a high-value xanthophyll carotenoid with broad applications in the pharmaceutical and nutraceutical industries, owing to its potent antioxidant properties and its efficacy in preventing age-related macular degeneration. In this study, we systematically optimized the culture conditions and medium composition for Lutimonas zeaxanthinifaciens YSD2104 T , a recently isolated marine bacterium, to enhance biomass and zeaxanthin production. Initial optimization via the one-factor-at-a-time (OFAT) approach established the culture conditions at 30 °C, pH 7.0, and 2% (w/v) NaCl. To identify the key nutritional components within the complex Marine Broth (MB), a fractional factorial design (FFD) was employed to screen eleven components. Among these, NaCl, yeast extract, ferric citrate, and peptone were identified as the most significant factors. Specifically, salinity and complex carbon and nitrogen sources significantly enhanced zeaxanthin biosynthesis, whereas ferric citrate primarily contributed to biomass accumulation. Subsequently, response surface methodology (RSM) using a central composite design was applied to determine the optimal concentrations and explore the interactive effects of these four components. The optimized medium containing 20.86 g L −1 NaCl, 2.8 g L −1 yeast extract, 0.02 g L −1 ferric citrate, and 4.01 g L −1 peptone was validated in a 3-L bioreactor (1.5-L working volume). Under these optimized conditions, biomass and zeaxanthin production achieved 1.4-fold and 1.7-fold increases, respectively, compared to the unoptimized MB formulation. These findings demonstrate that statistical optimization is an effective strategy for developing a highly productive fermentation process for zeaxanthin production by L. zeaxanthinifaciens YSD2104 T and support further development of this strain as a sustainable marine bioresource.
No takes yet. Share an insight, caveat, or question.
Jung et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: